Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.08.2023 | Case report

Fulvestrant/palbociclib

Extragenital lichen sclerosus: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Johnston S, et al. The development of diffuse extragenital lichen sclerosus in a patient on palbociclib and fulvestrant for metastatic breast cancer. British Journal of Dermatology 188 (Suppl. 4): iv90, Jun 2023. Available from: URL: http://doi.org/10.1093/bjd/ljad113.189 [abstract] Johnston S, et al. The development of diffuse extragenital lichen sclerosus in a patient on palbociclib and fulvestrant for metastatic breast cancer. British Journal of Dermatology 188 (Suppl. 4): iv90, Jun 2023. Available from: URL: http://​doi.​org/​10.​1093/​bjd/​ljad113.​189 [abstract]
Metadaten
Titel
Fulvestrant/palbociclib
Extragenital lichen sclerosus: case report
Publikationsdatum
01.08.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-44981-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Triamcinolone

Case report

Camrelizumab